Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $16.95.

Several research firms have commented on BWAY. HC Wainwright reissued a “buy” rating and issued a $14.00 target price on shares of Brainsway in a report on Friday, July 17th. Zacks Research downgraded shares of Brainsway from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. LADENBURG THALM/SH SH boosted their price objective on shares of Brainsway from $18.00 to $18.80 and gave the company a “buy” rating in a research report on Thursday, August 13th. Wall Street Zen upgraded Brainsway from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Brainsway in a report on Tuesday, July 21st.

Institutional Trading of Brainsway

Several institutional investors and hedge funds have recently modified their holdings of the business. Ballast Advisors LLC acquired a new stake in Brainsway in the first quarter valued at about $55,000. Bank of America Corp DE acquired a new position in Brainsway during the first quarter worth about $206,000. Royal Bank of Canada raised its stake in Brainsway by 84.2% during the first quarter. Royal Bank of Canada now owns 15,490 shares of the company’s stock worth $206,000 after acquiring an additional 7,080 shares in the last quarter. Masters Capital Management LLC raised its stake in Brainsway by 65.0% during the first quarter. Masters Capital Management LLC now owns 1,650,000 shares of the company’s stock worth $21,928,000 after acquiring an additional 650,000 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of Brainsway by 87.2% in the first quarter. Renaissance Technologies LLC now owns 518,420 shares of the company’s stock worth $6,890,000 after acquiring an additional 241,560 shares during the last quarter. 30.11% of the stock is currently owned by institutional investors.

Brainsway Stock Performance

BWAY opened at $14.66 on Friday. Brainsway has a 52-week low of $7.14 and a 52-week high of $17.40. The firm has a market cap of $588.31 million, a P/E ratio of 33.32 and a beta of 1.24. The business’s fifty day moving average is $15.20 and its 200-day moving average is $14.42.

Brainsway (NASDAQ:BWAY) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.04. Brainsway had a return on equity of 12.74% and a net margin of 15.65%.The business had revenue of $17.11 million during the quarter, compared to the consensus estimate of $16.54 million. On average, research analysts predict that Brainsway will post 0.34 earnings per share for the current fiscal year.

Brainsway Company Profile

Brainsway Ltd is a medical device company specializing in non-invasive neuromodulation therapies. Publicly traded on the NASDAQ under the symbol BWAY, the company develops and commercializes deep transcranial magnetic stimulation (Deep TMS) systems designed to treat a range of neuropsychiatric and neurological disorders. Brainsway’s technology aims to offer an alternative or complement to traditional pharmacological therapies by targeting precise brain regions with its patented coil designs.

The company’s flagship Deep TMS platform utilizes proprietary H-coil arrays engineered to reach deeper cortical structures than conventional TMS devices.